Artivion, Inc.
AORT
$23.04
-$1.10-4.56%
| Weiss Ratings | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.26 | |||
| Price History | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.76% | |||
| 30-Day Total Return | -18.47% | |||
| 60-Day Total Return | -21.12% | |||
| 90-Day Total Return | -17.80% | |||
| Year to Date Total Return | -17.95% | |||
| 1-Year Total Return | 8.12% | |||
| 2-Year Total Return | 80.28% | |||
| 3-Year Total Return | 7.87% | |||
| 5-Year Total Return | 24.88% | |||
| 52-Week High % Change | -25.33% | |||
| 52-Week Low % Change | 24.69% | |||
| Price | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $32.33 | |||
| 52-Week Low Price | $19.36 | |||
| 52-Week Low Price (Date) | May 01, 2024 | |||
| 52-Week High Price (Date) | Jan 16, 2025 | |||
| Valuation | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.02B | |||
| Enterprise Value | 1.32B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.32 | |||
| Earnings Per Share Growth | -57.45% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.60 | |||
| Price/Book (Q) | 3.67 | |||
| Enterprise Value/Revenue (TTM) | 3.41 | |||
| Price | $23.04 | |||
| Enterprise Value/EBITDA (TTM) | 25.39 | |||
| Enterprise Value/EBIT | 47.40 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 41.88M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.03 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.03 | |||
| Company Info | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (770) 419-3355 | |||
| Address | 1655 Roberts Boulevard NW Kennesaw, GA 30144 | |||
| Website | artivion.com | |||
| Country | United States | |||
| Year Founded | 1984 | |||
| Profitability | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.18% | |||
| Profit Margin | -3.43% | |||
| Management Effectiveness | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.21% | |||
| Return on Equity | -- | |||
| Income Statement | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 388.54M | |||
| Total Revenue (TTM) | 388.54M | |||
| Revenue Per Share | $9.28 | |||
| Gross Profit (TTM) | 248.78M | |||
| EBITDA (TTM) | 52.14M | |||
| EBIT (TTM) | 27.93M | |||
| Net Income (TTM) | -13.36M | |||
| Net Income Avl. to Common (TTM) | -13.36M | |||
| Total Revenue Growth (Q YOY) | 3.88% | |||
| Earnings Growth (Q YOY) | -314.67% | |||
| EPS Diluted (TTM) | -0.32 | |||
| EPS Diluted Growth (Q YOY) | -291.24% | |||
| Balance Sheet | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 53.46M | |||
| Cash Per Share (Q) | $1.28 | |||
| Total Current Assets (Q) | 290.08M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 276.20M | |||
| Current Ratio (Q) | 4.341 | |||
| Book Value Per Share (Q) | $6.58 | |||
| Total Assets (Q) | 789.10M | |||
| Total Current Liabilities (Q) | 66.82M | |||
| Total Debt (Q) | 362.26M | |||
| Total Liabilities (Q) | 512.90M | |||
| Total Common Equity (Q) | 276.20M | |||
| Cash Flow | AORT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -28.19M | |||
| Cash from Financing (TTM) | 2.20M | |||
| Net Change in Cash (TTM) | -5.48M | |||
| Levered Free Cash Flow (TTM) | 8.40M | |||
| Cash from Operations (TTM) | 22.24M | |||
